Calcium channel α2δ1 proteins mediate trigeminal neuropathic pain states associated with aberrant excitatory synaptogenesis

Journal of Biological Chemistry

Volumn 289, Issue 10, 2014, Pages 7025-7037

  Li, Kang Wu ^a   Yu, Yanhui Peter ^a   Zhou, Chunyi ^a   Kim, Doo Sik ^a,b   Lin, Bin ^a   Sharp, Kelli ^a   Steward, Oswald ^a   Luo, Z David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Kosin University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PROTEINS;

CALCIUM CHANNELS; NEUROPATHIC PAIN; NEUROPLASTICITY; OROFACIAL PAIN; PRESYNAPTIC; SYNAPTOGENESIS; TRIGEMINAL NERVES; UP-REGULATION;

HEALTH;

ANTISENSE OLIGONUCLEOTIDE; CALCIUM CHANNEL; CALCIUM CHANNEL ALPHA2 DELTA1 PROTEIN; GABAPENTIN; MISMATCH OLIGONUCLEOTIDE; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC CONSTRICTION INJURY; CONTROLLED STUDY; DISEASE ASSOCIATION; EXCITATORY POSTSYNAPTIC POTENTIAL; FACE PAIN; MALE; MINIATURE ENDPLATE POTENTIAL; MOUTH PAIN; NERVE CELL PLASTICITY; NERVE EXCITABILITY; NEUROPATHIC PAIN; NEUROPATHOLOGY; NONHUMAN; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD DORSAL HORN; SPINAL NERVE; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS; TRIGEMINAL NERVE INJURY; TRIGEMINAL NEUROPATHIC PAIN; TRIGEMINUS GANGLION; UPREGULATION;

GENE REGULATION; MOLECULAR PHARMACOLOGY; NEUROSCIENCE; PAIN; SYNAPTIC PLASTICITY;

ANIMALS; CALCIUM CHANNELS; DISEASE MODELS, ANIMAL; FACIAL PAIN; MALE; NEURALGIA; RATS; RATS, SPRAGUE-DAWLEY; TRIGEMINAL CAUDAL NUCLEUS; TRIGEMINAL GANGLION; TRIGEMINAL NERVE INJURIES;

EID: 84896802658     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.548990     Document Type: Article

References (60)

1. Hardt, J., Jacobsen, C., Goldberg, J., Nickel, R., and Buchwald, D. (2008) Prevalence of chronic pain in a representative sample in the United States. Pain Med. 9, 803-812
2. Clark, G. T. (2006) Persistent orodental pain, atypical odontalgia, and phantom tooth pain: when are they neuropathic disorders? J. Calif. Dent. Assoc. 34, 599-609
3. Vickers, E. R., and Cousins, M. J. (2000) Neuropathic orofacial pain. Part 2-diagnostic procedures, treatment guidelines and case reports. Aust. Endod. J. 26, 53-63
4. Gee, N. S., Brown, J. P., Dissanayake, V. U., Offord, J., Thurlow, R., and Woodruff, G. N. (1996) The novel anticonvulsant drug, gabapentin (Neurontin), binds to the 2 subunit of a calcium channel. J. Biol. Chem. 271, 5768-5776
5. Marais, E., Klugbauer, N., and Hofmann, F. (2001) Calcium channel 2 subunits-structure and gabapentin binding. Mol. Pharmacol. 59, 1243-1248
6. Mori, Y., Friedrich, T., Kim, M. S., Mikami, A., Nakai, J., Ruth, P., Bosse, E., Hofmann, F., Flockerzi, V., Furuichi, T., Mikoshiba, K., Imoto, K., Tanabe, T., and Numa, S. (1991) Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature 350, 398-402
7. Gurnett, C. A., De Waard, M., and Campbell, K. P. (1996) Dual function of the voltage-dependent Ca2 channel 2 subunit in current stimulation and subunit interaction. Neuron 16, 431-440
8. Williams, M. E., Feldman, D. H., McCue, A. F., Brenner, R., Velicelebi, G., Ellis, S. B., and Harpold, M. M. (1992) Structure and functional expression of 1, 2, and subunits of a novel human neuronal calcium channel subtype. Neuron 8, 71-84
9. Brust, P. F., Simerson, S., McCue, A. F., Deal, C. R., Schoonmaker, S., Williams, M. E., Veli̧elebi, G., Johnson, E. C., Harpold, M. M., and Ellis, S. B. (1993) Human neuronal voltage-dependent calcium channels: studies on subunit structure and role in channel assembly. Neuropharmacology 32, 1089-1102
10. Kang, M. G., Felix, R., and Campbell, K. P. (2002) Long-term regulation of voltage-gated Ca2 channels by gabapentin. FEBS Lett. 528, 177-182
11. Qin, N., Yagel, S., Momplaisir, M. L., Codd, E. E., and D'Andrea, M. R. (2002) Molecular cloning and characterization of the human voltagegated calcium channel 24 subunit. Mol. Pharmacol. 62, 485-496
12. Klugbauer, N., Lacinová, L., Marais, E., Hobom, M., and Hofmann, F. (1999) Molecular diversity of the calcium channel2 subunit. J. Neurosci. 19, 684-691
13. Ellis, S. B., Williams, M. E., Ways, N. R., Brenner, R., Sharp, A. H., Leung, A. T., Campbell, K. P., McKenna, E., Koch, W. J., Hui, A., Schwartz, A., and Harpold, M. M. (1988) Sequence and expression of mRNAs encoding the 1 and 2 subunits of a DHP-sensitive calcium channel. Science 241, 1661-1664
14. Bauer, C. S., Nieto-Rostro, M., Rahman, W., Tran-Van-Minh, A., Ferron, L., Douglas, L., Kadurin, I., Sri Ranjan, Y., Fernandez-Alacid, L., Millar, N. S., Dickenson, A. H., Lujan, R., and Dolphin, A. C. (2009) The increased trafficking of the calcium channel subunit 21 to presynaptic terminals in neuropathic pain is inhibited by the 2 ligand pregabalin. J. Neurosci. 29, 4076-4088
15. Luo, Z. D., Calcutt, N. A., Higuera, E. S., Valder, C. R., Song, Y. H., Svensson, C. I., and Myers, R. R. (2002) Injury type-specific calcium channel 21 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J. Pharmacol. Exp. Ther. 303, 1199-1205
16. Luo, Z. D., Chaplan, S. R., Higuera, E. S., Sorkin, L. S., Stauderman, K. A., Williams, M. E., and Yaksh, T. L. (2001) Upregulation of dorsal root ganglion 2 calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J. Neurosci. 21, 1868-1875
17. Xiao, W., Boroujerdi, A., Bennett, G. J., and Luo, Z. D. (2007) Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the 2 type-1 calcium channel subunit. Neuroscience 144, 714-720
18. Field, M. J., Oles, R. J., Lewis, A. S., McCleary, S., Hughes, J., and Singh, L. (1997) Gabapentin (Neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br. J. Pharmacol. 121, 1513-1522
19. Hunter, J. C., Gogas, K. R., Hedley, L. R., Jacobson, L. O., Kassotakis, L., Thompson, J., and Fontana, D. J. (1997) The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur. J. Pharmacol. 324, 153-160
20. Singh, L., Field, M. J., Ferris, P., Hunter, J. C., Oles, R. J., Williams, R. G., and Woodruff, G. N. (1996) The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine. Psychopharmacology 127, 1-9
21. Stanfa, L. C., Singh, L., Williams, R. G., and Dickenson, A. H. (1997) Gabapentin, ineffective in normal rats, markedly reduces C-fibre evoked responses after inflammation. Neuroreport 8, 587-590
22. Kernisant, M., Gear, R. W., Jasmin, L., Vit, J. P., and Ohara, P. T. (2008) Chronic constriction injury of the infraorbital nerve in the rat using modified syringe needle. J. Neurosci. Methods 172, 43-47
23. Vos, B. P., Strassman, A. M., and Maciewicz, R. J. (1994) Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerve. J. Neurosci. 14, 2708-2723
24. Dixon, W. J. (1980) Efficient analysis of experimental observations. Annu. Rev. Pharmacol. Toxicol. 20, 441-462
25. Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M., and Yaksh, T. L. (1994) Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53, 55-63
26. Iwata, K., Imamura, Y., Honda, K., and Shinoda, M. (2011) Physiological mechanisms of neuropathic pain: the orofacial region. Int. Rev. Neurobiol. 97, 227-250
27. Basso, D. M., Beattie, M. S., and Bresnahan, J. C. (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1-21
28. Boroujerdi, A., Zeng, J., Sharp, K., Kim, D., Steward, O., and Luo, Z. D. (2011) Calcium channel 21 protein upregulation in dorsal spinal cord mediates spinal cord injury-induced neuropathic pain states. Pain 152, 649-655
29. Nguyen, D., Deng, P., Matthews, E. A., Kim, D. S., Feng, G., Dickenson, A. H., Xu, Z. C., and Luo, Z. D. (2009) Enhanced pre-synaptic glutamate release in deep-dorsal horn contributes to calcium channel 21 protein-mediated spinal sensitization and behavioral hypersensitivity. Mol. Pain 5, 6
30. Shimoyama, M., Shimoyama, N., and Hori, Y. (2000) Gabapentin affects glutamatergic excitatory neurotransmission in the rat dorsal horn. Pain 85, 405-414
31. Peyronnard, J. M., Charron, L., Messier, J. P., Lavoie, J., Leger, C., and Faraco-Cantin, F. (1989) Changes in lectin binding of lumbar dorsal root ganglia neurons and peripheral axons after sciatic and spinal nerve injury in the rat. Cell Tissue Res. 257, 379-388
32. Neumann, S., Braz, J. M., Skinner, K., Llewellyn-Smith, I. J., and Basbaum, A. I. (2008) Innocuous, not noxious, input activates PKC interneurons of the spinal dorsal horn via myelinated afferent fibers. J. Neurosci. 28, 7936-7944
33. Silverman, J. D., and Kruger, L. (1990) Selective neuronal glycoconjugate expression in sensory and autonomic ganglia: relation of lectin reactivity to peptide and enzyme markers. J. Neurocytol. 19, 789-801
34. Snider, W. D., and McMahon, S. B. (1998) Tackling pain at the source: new ideas about nociceptors. Neuron 20, 629-632
35. Hunt, S. P., and Mantyh, P. W. (2001) The molecular dynamics of pain control. Nat. Rev. Neurosci. 2, 83-91
36. Li, C. Y., Song, Y. H., Higuera, E. S., and Luo, Z. D. (2004) Spinal dorsal horn calcium channel 21 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia. J. Neurosci. 24, 8494-8499
37. Laird, M. A., and Gidal, B. E. (2000) Use of gabapentin in the treatment of neuropathic pain. Ann. Pharmacother. 34, 802-807
38. Backonja, M., and Glanzman, R. L. (2003) Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin. Ther. 25, 81-104
39. Dworkin, R. H., O'Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., Portenoy, R. K., Rice, A. S., Stacey, B. R., Treede, R. D., Turk, D. C., and Wallace, M. S. (2007) Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132, 237-251
40. Field, M. J., McCleary, S., Hughes, J., and Singh, L. (1999) Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain 80, 391-398
41. Hwang, J. H., and Yaksh, T. L. (1997) Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg. Anesth. 22, 249-256
42. Li, K.-W., Kim, D.-S., Zaucke, F., and Luo, Z. D. (2013) Trigeminal nerve injury induced thrombospondin-4 upregulation contributes to orofacial neuropathic pain states in a rat model. Eur. J. Pain 10.1002/j.1532-2149.2013. 00396.x
43. Eroglu, C., Allen, N. J., Susman, M. W., O'Rourke, N. A., Park, C. Y., Ozkan, E., Chakraborty, C., Mulinyawe, S. B., Annis, D. S., Huberman, A. D., Green, E. M., Lawler, J., Dolmetsch, R., Garcia, K. C., Smith, S. J., Luo, Z. D., Rosenthal, A., Mosher, D. F., and Barres, B. A. (2009) Gabapentin receptor 21 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 139, 380-392
44. Moechars, D., Weston, M. C., Leo, S., Callaerts-Vegh, Z., Goris, I., Daneels, G., Buist, A., Cik, M., van der Spek, P., Kass, S., Meert, T., D'Hooge, R., Rosenmund, C., and Hampson, R. M. (2006) Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain. J. Neurosci. 26, 12055-12066
45. Rogoz, K., Lagerström, M. C., Dufour, S., and Kullander, K. (2012) VGLUT2-dependent glutamatergic transmission in primary afferents is required for intact nociception in both acute and persistent pain modalities. Pain 153, 1525-1536
46. Leo, S., Moechars, D., Callaerts-Vegh, Z., D'Hooge, R., and Meert, T. (2009) Impairment of VGLUT2 but not VGLUT1 signaling reduces neuropathy-induced hypersensitivity. Eur. J. Pain 13, 1008-1017
47. Seal, R. P., Wang, X., Guan, Y., Raja, S. N., Woodbury, C. J., Basbaum, A. I., and Edwards, R. H. (2009) Injury-induced mechanical hypersensitivity requires C-low threshold mechanoreceptors. Nature 462, 651-655
48. Brittain, J. M., Duarte, D. B., Wilson, S. M., Zhu, W., Ballard, C., Johnson, P. L., Liu, N., Xiong, W., Ripsch, M. S., Wang, Y., Fehrenbacher, J. C., Fitz, S. D., Khanna, M., Park, C. K., Schmutzler, B. S., Cheon, B. M., Due, M. R., Brustovetsky, T., Ashpole, N. M., Hudmon, A., Meroueh, S. O., Hingtgen, C. M., Brustovetsky, N., Ji, R. R., Hurley, J. H., Jin, X., Shekhar, A., Xu, X. M., Oxford, G. S., Vasko, M. R., White, F. A., and Khanna, R. (2011) Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca2 channel complex. Nat. Med. 17, 822-829
49. Valder, C. R., Liu, J. J., Song, Y. H., and Luo, Z. D. (2003) Coupling gene chip analyses and rat genetic variances in identifying potential target genes that may contribute to neuropathic allodynia development. J. Neurochem. 87, 560-573
50. Kim, S. H., and Chung, J. M. (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50, 355-363
51. Li, C. Y., Zhang, X. L., Matthews, E. A., Li, K. W., Kurwa, A., Boroujerdi, A., Gross, J., Gold, M. S., Dickenson, A. H., Feng, G., and Luo, Z. D. (2006) Calcium channel 21 subunit mediates spinal hyperexcitability in pain modulation. Pain 125, 20-34
52. Sweitzer, S. M., Colburn, R. W., Rutkowski, M., and DeLeo, J. A. (1999) Acute peripheral inflammation induces moderate glial activation and spinal IL-1 expression that correlates with pain behavior in the rat. Brain Res. 829, 209-221
53. Clark, A. K., Gentry, C., Bradbury, E. J., McMahon, S. B., and Malcangio, M. (2007) Role of spinal microglia in rat models of peripheral nerve injury and inflammation. Eur. J. Pain. 11, 223-230
54. Cao, H., and Zhang, Y. Q. (2008) Spinal glial activation contributes to pathological pain states. Neurosci. Biobehav. Rev. 32, 972-983
55. Sun, S., Cao, H., Han, M., Li, T. T., Zhao, Z. Q., and Zhang, Y. Q. (2008) Evidence for suppression of electroacupuncture on spinal glial activation and behavioral hypersensitivity in a rat model of monoarthritis. Brain Res. Bull. 75, 83-93
56. Hashizume, H., DeLeo, J. A., Colburn, R. W., and Weinstein, J. N. (2000) Spinal glial activation and cytokine expression after lumbar root injury in the rat. Spine 25, 1206-1217
57. Rogawski, M. A., and Löscher, W. (2004) The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat. Med. 10, 685-692
58. Wamil, A. W., and McLean, M. J. (1994) Limitation by gabapentin of high frequency action potential firing by mouse central neurons in cell culture. Epilepsy Res. 17, 1-11
59. Gordh, T. E., Stubhaug, A., Jensen, T. S., Arnèr, S., Biber, B., Boivie, J., Mannheimer, C., Kalliomäki, J., and Kalso, E. (2008) Gabapentin in traumatic nerve injury pain: a randomized, double-blind, placebo-controlled, cross-over, multi-center study. Pain 138, 255-266
60. Kim, D. S., Li, K. W., Boroujerdi, A., Peter Yu, Y., Zhou, C. Y., Deng, P., Park, J., Zhang, X., Lee, J., Corpe, M., Sharp, K., Steward, O., Eroglu, C., Barres, B., Zaucke, F., Xu, Z. C., and Luo, Z. D. (2012) Thrombospondin-4 contributes to spinal sensitization and neuropathic pain states. J. Neurosci. 32, 8977-8987